Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00472485 · ClinicalTrials.gov registry record · NA
Study of Eye Movement Testing and Therapy
A NA study, sponsored by Ohio State University.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT00472485: Completed NA study, sponsored by Ohio State University.
NCT00472485 is a NA study that has completed, run by Ohio State University. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00472485, a NA study, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the ability of several eye movement monitors, used in clinical practice, to identify children with poor reading eye movements. A second purpose of the study is to evaluate the effectiveness of eye movement therapy.
Interventions
- PROCEDURE eye movement therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Phase | NA |
What the finished NCT00472485 record still lists
NCT00472485 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which eye movement therapy is the first listed.
NCT00472485 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00472485 about?
NCT00472485 is a clinical study titled "Study of Eye Movement Testing and Therapy". The purpose of this study is to determine the ability of several eye movement monitors, used in clinical practice, to identify children with poor reading eye movements. A second purpose of the study is to evaluate the effectiveness of eye movement therapy.
What is the current status of trial NCT00472485?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants.
What interventions are being tested in trial NCT00472485?
The interventions under investigation include: eye movement therapy (PROCEDURE).
Who is sponsoring clinical trial NCT00472485?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00472485's enrollment target sits among peer trials
40 1447th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models